Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Srđan Stefanović, Slobodan M. Janković, Milan Novaković, Marko Milosavljević & Marko Folić. (2018) Pharmacodynamics and common drug-drug interactions of the third-generation antiepileptic drugs. Expert Opinion on Drug Metabolism & Toxicology 14:2, pages 153-159.
Read now
Read now
Zhixiao Wang, Xuan Li, Annette Powers & Jose E Cavazos. (2015) Outcomes associated with switching from monotherapy to adjunctive therapy for patients with partial onset seizures. Expert Review of Pharmacoeconomics & Outcomes Research 15:2, pages 349-355.
Read now
Read now
Nasreen Khan, Dhvani Shah, Vanita Tongbram, Lara Verdian & Neil Hawkins. (2013) The efficacy and tolerability of perampanel and other recently approved anti-epileptic drugs for the treatment of refractory partial onset seizure: a systematic review and Bayesian network meta-analysis. Current Medical Research and Opinion 29:8, pages 1001-1013.
Read now
Read now
Articles from other publishers (25)
Shantilal Padhiyar, Kamlesh M Jivani, Jagat Upadhyay, Tejas Patel & Bhanubhai Suhagia. (2022) Development and Validation of Stability-Indicating High-Performance Liquid Chromatography Method for Estimation of Lacosamide in Bulk and Its Pharmaceutical Dosage Form. Journal of Chromatographic Science.
Crossref
Crossref
Bruna Nucera, Francesco Brigo, Eugen Trinka & Gudrun Kalss. (2022) Treatment and care of women with epilepsy before, during, and after pregnancy: a practical guide. Therapeutic Advances in Neurological Disorders 15, pages 175628642211016.
Crossref
Crossref
Eugen Trinka, Wan Tsong, Sydney Toupin, Anna Patten, Katy Wilson, Jaana Isojarvi & Daniel James. (2020) A systematic review and indirect treatment comparison of perampanel versus brivaracetam as adjunctive therapy in patients with focal-onset seizures with or without secondary generalization. Epilepsy Research 166, pages 106403.
Crossref
Crossref
Patrick M. Wieruszewski, Arnaldo Lopez-Ruiz, Robert C. Albright, Jennifer E. Fugate & Erin Frazee Barreto. (2018) Lacosamide Pharmacokinetics in a Critically Ill Patient During Continuous Renal Replacement Therapy. Journal of Pharmacy Practice 33:3, pages 395-398.
Crossref
Crossref
Li-na Zhu, Deng Chen, Ge Tan, Hai-jiao Wang, Shanshan Chu & Ling Liu. (2020) The tolerability and safety profile of eslicarbazepine acetate in neurological disorders. Journal of the Neurological Sciences 413, pages 116772.
Crossref
Crossref
Jesse Fishman, Melinda Martin, David M. Labiner, Carolyn R. Lew & Barbara H. Johnson. (2019) Healthcare resource utilization and costs before and after lacosamide initiation as adjunctive therapy among patients with epilepsy in the United States. Epilepsy & Behavior 99, pages 106331.
Crossref
Crossref
Ilker Gunyeli, Mustafa Saygin & Ozlem Ozmen. (2019) Overall systematic approach to sepsis damages on urogenital tissues: protective power of lacosamide. Archives of Gynecology and Obstetrics 300:4, pages 941-955.
Crossref
Crossref
Isabelle Beuchat, Jan Novy & Andrea O. Rossetti. (2018) Newer Antiepileptic Drugs for Status Epilepticus in Adults: What’s the Evidence?. CNS Drugs 32:3, pages 259-267.
Crossref
Crossref
Shery Jacob & Anroop B. Nair. (2016) An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs. Drugs in R&D 16:4, pages 303-316.
Crossref
Crossref
Deng Chen, Yan Lin, Tao Chen, Qin Zhang, Yan Lin, Yang Si, Wen-wu Zhang, Da Xu & Ling Liu. (2016) Dose effects of lacosamide as add-on therapy for partial-onset seizure in adult. Neurological Sciences 37:6, pages 907-920.
Crossref
Crossref
Vanessa Paquette, Celia Culley, Erica D. Greanya & Mary H.H. Ensom. (2015) Lacosamide as adjunctive therapy in refractory epilepsy in adults: A systematic review. Seizure 25, pages 1-17.
Crossref
Crossref
Sofia Markoula, Rute Teotonio, Neville Ratnaraj, John S. Duncan, Josemir W. Sander & Philip N. Patsalos. (2014) Lacosamide Serum Concentrations in Adult Patients With Epilepsy. Therapeutic Drug Monitoring 36:4, pages 494-498.
Crossref
Crossref
Marlon G. Saria, Courtney Corle, Jethro HuJeremy D. RudnickSurasak PhuphanichMaciej M. MrugalaLaura K. CrewDaniela A. BotaBeverly Dan Fu, Ryan Y. Kim, Tiffany Brown, Homira FeelyJoanne Brechlin, Bradley D. Brown, Jan Drappatz, Patrick Y. Wen, Clark C. ChenBob CarterJong Woo Lee & Santosh Kesari. (2013) Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors. Journal of Neurosurgery 118:6, pages 1183-1187.
Crossref
Crossref
Gaetano Zaccara, Piero Perucca, Giulia Loiacono, Fabio Giovannelli & Alberto Verrotti. (2012) The adverse event profile of lacosamide: A systematic review and meta‐analysis of randomized controlled trials. Epilepsia 54:1, pages 66-74.
Crossref
Crossref
Dimitrios Chatzistefanidis, Eleni Karvouni, Athanassios P. Kyritsis & Sofia Markoula. (2013) First Case of Lacosamide-Induced Psychosis. Clinical Neuropharmacology 36:1, pages 27-28.
Crossref
Crossref
Carlos Casas-Fernández, Antonio Martínez-Bermejo, Miguel Rufo-Campos, Patricia Smeyers-Durá, José L. Herranz-Fernández, Salvador Ibáñez-Micó, Jaume Campistol-Plana, Helena Alarcón-Martínez & Jaime Campos-Castelló. (2012) Efficacy and Tolerability of Lacosamide in the Concomitant Treatment of 130 Patients Under 16 Years of Age with Refractory Epilepsy. Drugs in R&D 12:4, pages 187-197.
Crossref
Crossref
James W. Wheless. 2012. Epilepsy in Children and Adolescents. Epilepsy in Children and Adolescents
175
192
.
H. B. Edwards, A. G. Cole, A. S. Griffiths, B. Lin, A. Bean & G. L. Krauss. (2012) Minimizing pharmacodynamic interactions of high doses of lacosamide. Acta Neurologica Scandinavica 125:4, pages 228-233.
Crossref
Crossref
L. Mnatsakanyan, J.M. Chung, E.I. Tsimerinov & D.S. Eliashiv. (2012) Intravenous Lacosamide in refractory nonconvulsive status epilepticus. Seizure 21:3, pages 198-201.
Crossref
Crossref
Danièle Bentué-Ferrer, Olivier Tribut & Marie-Clémence Verdier. (2012) Suivi thérapeutique pharmacologique du lacosamide. Therapies 67:2, pages 151-155.
Crossref
Crossref
Volker Briese. 2011. Arzneimittel und Nahrungsergänzungsmittel in Schwangerschaft und Stillzeit. Arzneimittel und Nahrungsergänzungsmittel in Schwangerschaft und Stillzeit
55
58
.
Laura M.F.F. Guilhoto, Tobias Loddenkemper, Vasu D. Gooty, Alexander Rotenberg, Masanori Takeoka, Frank H. Duffy, David Coulter, David Urion, Blaise F. Bourgeois & Sanjeev V. Kothare. (2011) Experience With Lacosamide in a Series of Children With Drug-Resistant Focal Epilepsy. Pediatric Neurology 44:6, pages 414-419.
Crossref
Crossref
. (2011) Current World Literature. Current Opinion in Neurology 24:2, pages 183-190.
Crossref
Crossref
Paolo Prunetti & Emilio Perucca. (2011) New and forthcoming anti-epileptic drugs. Current Opinion in Neurology 24:2, pages 159-164.
Crossref
Crossref
Steve Chung, Elinor Ben-Menachem, Michael R. Sperling, William Rosenfeld, Nathan B. Fountain, Selim Benbadis, David Hebert, Jouko Isojärvi & Pamela Doty. (2010) Examining the Clinical Utility of Lacosamide. CNS Drugs 24:12, pages 1041-1054.
Crossref
Crossref